BlackRock, Inc. - 30 Sep 2025 SCHEDULE 13G/A Report for LIGAND PHARMACEUTICALS INC Common Stock (LGND)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: LIGAND PHARMACEUTICALS INC Common Stock
Symbol: LGND
Shares outstanding: 19.6M shares
Disclosed Ownership: 2.84M shares
Ownership: 14.5%
Form type: SCHEDULE 13G/A
Filing time: 17 Oct 2025, 17:31:38 UTC
Date of event: 30 Sep 2025
Previous filing: 05 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	14.5%	2.84M	2.79M	0	Spencer Fleming	Managing Director